Biocure Technology BICTF Stock
Biocure Technology Price Chart
Biocure Technology BICTF Financial and Trading Overview
| Biocure Technology stock price | 0.03 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.0035 - 0.06 USD |
| Volume | 200 USD |
| Avg. Volume | 0 USD |
| Market Cap | 6.35M USD |
| Beta (5Y Monthly) | 2.568542 |
| PE Ratio (TTM) | 1.5100001 |
| EPS (TTM) | -0.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BICTF Valuation Measures
| Enterprise Value | 1.44M USD |
| Trailing P/E | 1.5100001 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biocure Technology Stock Price History
| Beta (5Y Monthly) | 2.568542 |
| 52-Week Change | -76.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.0035 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
BICTF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 108.92M |
| Float | 108.82M |
| Short Ratio | N/A |
| % Held by Insiders | 25.71% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.32% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -316251 USD |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.8K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 82.54K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.02 |
| Book Value Per Share (mrq) | -0.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -688696 USD |
| Levered Free Cash Flow (ttm) | 2.71M USD |
Profile of Biocure Technology
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1055 West Hastings Street |
| ZIP | V6E 2E9 |
| Phone | 604-609-7146 |
| Website | https://www.biocuretech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada.
Q&A For Biocure Technology Stock
What is a current BICTF stock price?
Biocure Technology BICTF stock price today per share is 0.03 USD.
How to purchase Biocure Technology stock?
You can buy BICTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biocure Technology?
The stock symbol or ticker of Biocure Technology is BICTF.
Which industry does the Biocure Technology company belong to?
The Biocure Technology industry is Biotechnology.
How many shares does Biocure Technology have in circulation?
The max supply of Biocure Technology shares is 861.88M.
What is Biocure Technology Price to Earnings Ratio (PE Ratio)?
Biocure Technology PE Ratio is now.
What was Biocure Technology earnings per share over the trailing 12 months (TTM)?
Biocure Technology EPS is -0.25 USD over the trailing 12 months.
Which sector does the Biocure Technology company belong to?
The Biocure Technology sector is Healthcare.